The clinical outcome of different doses of progesterone used for ovarian stimulation in normalovulatory women

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-ONRC-14005127

Enrollment

Unknown

Registered

2014-08-19

Start date

2014-08-19

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

low MPA group:MPA 10mg/d

high MPA group:MPA 10mg/d

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Infertility women, aged 20-40 years, BMI 18-25 kg/m2, normal mentrual cycle (23-35 days). The infertility was caused by tubal factor, male factor or unexplained infertility.

Exclusion criteria

Exclusion criteria: Subjects with less than 3 or >20 basal antral follicles on ultrasound (10 mIU/ml; with functional cyst in ovaries on the day 3 of menstrual cycle; clinically significant systemic disease; any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

Measure	Time frame
number of oocyte retrieval;	—

Secondary

Measure	Time frame
number of fertilized oocytes;number of viable embryos;number of mature oocytes;clinical pregnancy rate;incidence of premature LH surge;	—

Countries

China

Contacts

Public ContactYanping Kuang

kuangyanp@126.com+86 021-53078108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026